Séverine Graf
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Séverine Graf has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Claude Pichard
Department of Clinical Nutrition, Geneva University Hospital, Geneva, Switzerland
6 shared publications - Claudia-Paula Heidegger
Division of Intensive Care, Department of Acute Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland
6 shared publications - Laurence Genton
Clinical Nutrition, Geneva University Hospitals and University of Geneva, Geneva, Switzerland
4 shared publications - Taku Oshima
Division of Disaster and Emergency Medicine, Department of Surgery Related, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan
4 shared publications - Yves Marc Dupertuis
Clinical Nutrition, Geneva University Hospital, Geneva, Switzerland
2 shared publications - Aissam Lyazidi
Institut Supérieur des Sciences de la Santé, Laboratory Rayonnement-Matiére et Instrumentation, Université Hassan 1er, Settat, Morocco
1 shared publication
Latest Publications
- 1 August 2019
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 32, 50-55
In vitro validation of indirect calorimetry device developed for the ICALIC project against mass spectrometry
- 1 August 2019
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 32, 50-55
In vitro validation of indirect calorimetry device developed for the ICALIC project against mass spectrometry
- 1 December 2017
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 22, 71-75
Methods to validate the accuracy of an indirect calorimeter in the in-vitro setting
- 1 December 2017
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 22, 71-75
Methods to validate the accuracy of an indirect calorimeter in the in-vitro setting
- 1 February 2017
- Published by Elsevier in Clinical Nutrition
- Vol. 36 (1) , 224-228
Energy expenditure in mechanically ventilated patients: The weight of body weight!
- 1 February 2017
- Published by Elsevier in Clinical Nutrition
- Vol. 36 (1) , 224-228
Energy expenditure in mechanically ventilated patients: The weight of body weight!
- Open Access
- 1 January 2017
- Published by Elsevier in Annals of Intensive Care
- Vol. 7 (1) , 64
Can proportional ventilation modes facilitate exercise in critically ill patients? A physiological cross-over study
- 1 January 2017
- Published by Elsevier in Annals of Intensive Care
- Vol. 7 (1) , 64
Open AccessCan proportional ventilation modes facilitate exercise in critically ill patients? A physiological cross-over study
- 1 February 2015
- Published by Elsevier in Clinical Nutrition
- Vol. 34 (1) , 60-65
Evaluation of three indirect calorimetry devices in mechanically ventilated patients: Which device compares best with the Deltatrac II®? A prospective observational study
- 1 February 2015
- Published by Elsevier in Clinical Nutrition
- Vol. 34 (1) , 60-65
Evaluation of three indirect calorimetry devices in mechanically ventilated patients: Which device compares best with the Deltatrac II®? A prospective observational study
- 1 December 2013
- Published by Elsevier in Clinical Nutrition
- Vol. 32 (6) , 1067-1072
Comparison of three indirect calorimetry devices and three methods of gas collection: A prospective observational study
- 1 December 2013
- Published by Elsevier in Clinical Nutrition
- Vol. 32 (6) , 1067-1072
Comparison of three indirect calorimetry devices and three methods of gas collection: A prospective observational study
- Open Access
- 24 July 2013
- Published by Springer Nature in Critical Care
- Vol. 17 (4) , R153
Diarrhoea in the ICU: respective contribution of feeding and antibiotics
Introduction: Diarrhoea is frequently reported in the ICU. Little is known about diarrhoea incidence and the role of the different risk factors alone or in combination. This prospective observational study aims at determining diarrhoea incidence and risk factors in the first 2 weeks of ICU stay, focusing on the respective contribution of feeding, antibiotics, and antifungal drugs. Methods: Out of 422 patients consecutively admitted into a mixed medical–surgical ICU during a 2-month period, 278 patients were included according to the following criteria: ICU stay >24 hours, no admission diagnosis of gastrointestinal bleeding, and absence of enterostomy or colostomy. Diarrhoea was defined as at least three liquid stools per day. Diarrhoea episodes occurring during the first day in the ICU, related to the use of laxative drugs or Clostridium difficile infection, were not analysed. Multivariate and stratified analyses were performed to determine diarrhoea risk factors, and the impact of the combination of enteral nutrition (EN) with antibiotics or antifungal drugs. Results: A total of 1,595 patient-days were analysed. Diarrhoea was observed in 38 patients (14%) and on 83 patient-days (incidence rate: 5.2 per 100 patient-days). The median day of diarrhoea onset was the sixth day, and 89% of patients had ≤4 diarrhoea days. The incidence of C. difficile infection was 0.7%. Diarrhoea risk factors were EN covering >60% of energy target (relative risk = 1.75 (1.02 to 3.01)), antibiotics (relative risk = 3.64 (1.26 to 10.51)) and antifungal drugs (relative risk = 2.79 (1.16 to 6.70)). EN delivery per se was not a diarrhoea risk factor. In patients receiving >60% of energy target by EN, diarrhoea risk was increased by the presence of antibiotics (relative risk = 4.8 (2.1 to 13.7)) or antifungal drugs (relative risk = 5.0 (2.8 to 8.7)). Conclusion: Diarrhoea incidence during the first 2 weeks in a mixed population of patients in a tertiary ICU is 14%. Diarrhoea risk factors are EN covering >60% of energy target, use of antibiotics, and use of antifungal drugs. The combination of EN covering >60% of energy target with antibiotics or antifungal drugs increases the incidence of diarrhoea.
- 24 July 2013
- Published by Springer Nature in Critical Care
- Vol. 17 (4) , R153
Open AccessDiarrhoea in the ICU: respective contribution of feeding and antibiotics
Introduction: Diarrhoea is frequently reported in the ICU. Little is known about diarrhoea incidence and the role of the different risk factors alone or in combination. This prospective observational study aims at determining diarrhoea incidence and risk factors in the first 2 weeks of ICU stay, focusing on the respective contribution of feeding, antibiotics, and antifungal drugs. Methods: Out of 422 patients consecutively admitted into a mixed medical–surgical ICU during a 2-month period, 278 patients were included according to the following criteria: ICU stay >24 hours, no admission diagnosis of gastrointestinal bleeding, and absence of enterostomy or colostomy. Diarrhoea was defined as at least three liquid stools per day. Diarrhoea episodes occurring during the first day in the ICU, related to the use of laxative drugs or Clostridium difficile infection, were not analysed. Multivariate and stratified analyses were performed to determine diarrhoea risk factors, and the impact of the combination of enteral nutrition (EN) with antibiotics or antifungal drugs. Results: A total of 1,595 patient-days were analysed. Diarrhoea was observed in 38 patients (14%) and on 83 patient-days (incidence rate: 5.2 per 100 patient-days). The median day of diarrhoea onset was the sixth day, and 89% of patients had ≤4 diarrhoea days. The incidence of C. difficile infection was 0.7%. Diarrhoea risk factors were EN covering >60% of energy target (relative risk = 1.75 (1.02 to 3.01)), antibiotics (relative risk = 3.64 (1.26 to 10.51)) and antifungal drugs (relative risk = 2.79 (1.16 to 6.70)). EN delivery per se was not a diarrhoea risk factor. In patients receiving >60% of energy target by EN, diarrhoea risk was increased by the presence of antibiotics (relative risk = 4.8 (2.1 to 13.7)) or antifungal drugs (relative risk = 5.0 (2.8 to 8.7)). Conclusion: Diarrhoea incidence during the first 2 weeks in a mixed population of patients in a tertiary ICU is 14%. Diarrhoea risk factors are EN covering >60% of energy target, use of antibiotics, and use of antifungal drugs. The combination of EN covering >60% of energy target with antibiotics or antifungal drugs increases the incidence of diarrhoea.